MARIZYME, INC. Quarterly Debt-to-equity in % from Q3 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Marizyme, Inc. quarterly Debt-to-equity history and growth rate from Q3 2011 to Q2 2024.
  • Marizyme, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -318 %, a 366% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -318 -438 -366% Jun 30, 2024
Q1 2024 -489 -568 -725% Mar 31, 2024
Q4 2023 -3.37K -3.43K -5725% Dec 31, 2023
Q3 2023 739 +692 +1446% Sep 30, 2023
Q2 2023 120 +77.1 +181% Jun 30, 2023
Q1 2023 78.3 +41.8 +114% Mar 31, 2023
Q4 2022 59.8 +33.3 +126% Dec 31, 2022
Q3 2022 47.8 +30.6 +178% Sep 30, 2022
Q2 2022 42.6 +33.3 +361% Jun 30, 2022
Q1 2022 36.6 +33.9 +1261% Mar 31, 2022
Q4 2021 26.5 +24.4 +1181% Dec 31, 2021
Q3 2021 17.2 +16 +1349% Sep 30, 2021
Q2 2021 9.24 +8.19 +786% Jun 30, 2021
Q1 2021 2.69 +1.85 +221% Mar 31, 2021
Q4 2020 2.07 +1.5 +262% Dec 31, 2020
Q3 2020 1.19 +0.81 +218% Sep 30, 2020
Q2 2020 1.04 +0.66 +175% Jun 30, 2020
Q1 2020 0.84 Mar 31, 2020
Q4 2019 0.57 Dec 31, 2019
Q3 2019 0.37 Sep 30, 2019
Q2 2019 0.38 Jun 30, 2019
Q1 2018 18.2 Mar 31, 2018
Q4 2017 13.2 Dec 31, 2017
Q3 2017 9.23 Sep 30, 2017
Q4 2013 47.5 -13.8 -22.6% Dec 31, 2013
Q3 2013 50.3 -20 -28.5% Sep 30, 2013
Q2 2013 52.4 -17.2 -24.7% Jun 30, 2013
Q1 2013 55.8 -13.2 -19.1% Mar 31, 2013
Q4 2012 61.3 -6.73 -9.89% Dec 31, 2012
Q3 2012 70.4 +5.04 +7.72% Sep 30, 2012
Q2 2012 69.6 Jun 30, 2012
Q1 2012 68.9 Mar 31, 2012
Q4 2011 68.1 Dec 31, 2011
Q3 2011 65.3 Sep 30, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.